Effects of Fenofibrate on Adipocytokine Levels In Hypertriglyceridemic Patients

Phase 4

Completed

• Conditions: Hypertriglyceridemia
• Interventions: Drug: fenofibrate

• Registration Number: NCT00745407
• Lead Sponsor: Gachon University Gil Medical Center

Brief Summary

Fenofibrate increases adiponectin levels, but reduces leptin levels

Detailed Description

Not available

Study Timeline

• Study Start: 2005-01
• Study Completion: 2008-08
• Status Verified: 2008-09
• Study First Submitted: 2008-09-02
• Study First Submitted QC: 2008-09-02
• Last Update Submitted: 2008-09-02
• Study First Posted: 2008-09-03
• Last Update Posted: 2008-09-03

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• hypertriglyceridemia

Exclusion Criteria

• chronic liver disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
fenofibrate 160 mg, placebo	fenofibrate	-

Trial Locations

Locations (1)

Gil Medical Center; 🇰🇷 Incheon, Korea, Republic of